Skip to main content

Anaphylaxis References

pdfASCIA HP Anaphylaxis References 2022210.89 KB  

Anaphylaxis. Emergency management for health professionals wall chart. (2022). Australian Prescriber, 45 (100).

Anagnostou, A., Sharma, V., Herbert, L., & Turner, P. J. (2022). Fatal food anaphylaxis: distinguishing fact from fiction. J Allergy Clin Immunol, 10(1), 11-17.

Anagnostou, K. & Turner, P. (2019). Myths, facts and controversies in the diagnosis and management of anaphylaxis. British Med J, 104, 83-90.

Avery, N. J., King, R. M., Knight, S., & Hourihane, J. O. (2003). Assessment of quality of life in children with peanut allergy. Pediatr Allergy Immunol, 14(5), 378-382.

Baumgart, K., Brown, S., Gold, M. & Zeigler, J., ASCIA guidelines for prevention of food anaphylactic reactions in schools, preschools and child‐care centres (2004). J Paediatr Child Health, 40, 669-671.

Bock, S. A., Munoz-Furlong, A., & Sampson, H. A. (2001). Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol, 107(1), 191-3.

Bock, S. A., Munoz-Furlong, A., & Sampson, H. A. (2007). Further fatalities, caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol, 119(4), 1016-1018.

Bock, S. A., Kelso, J. M., & Feldweg, A. M. (ed). (2010). Fatal Anaphylaxis. UpToDate.

Boyce, J. A., Assa'ad, A., Burks, A. W., Jones, S. M., Sampson, H. A., Wood, R. A., … Schwaninger, J. M. (2010). Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol, 126(6 Suppl), S1-S58.

Brooke-Taylor, S. (2007). Development of VITAL allergen action levels grid: Explanatory notes. Updated 2019.

Brown, J. C., Tuuri, R. E., Akhter, S., Guerra, L. D., Goodman, I. S., … Park, E., (2016). Lacerations and Embedded Needles Caused by Epinephrine Autoinjector Use in Children. Ann Emerg Med, 67(3), 307-315.e8.

Brown, J. C. (2018). Epinephrine, autoinjectors, and anaphyalxis: challenges of dose, depth and device. Ann Allergy Asthma Immunol, 121, 53-60.

Brown, S. G. A., Blackman, K. E., Stenlake, V., & Heddle, R. J., (2004). Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J, 21(2), 149-154.

Brown, S. G. A., Mullins, R. J., & Gold, M. S. (2006). Anaphylaxis: diagnosis and management. MJA, 185(5), 283-289.

Campbell, D. E., Anaphylaxis Management: Time to Re-evaluate the Role of Cortiscosteroids. (2019). J Allergy Clin Immunol, 7(7), 2239-2240.

Campbell, R. l., Bellolio, M. F., Knutson, B. D., Bellamkonda, V.R., Fedko, M. G., Nestler, D. M., & Hess, E. P. (2015). Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract, 3(1), 76-80.

Cardona, V., Ansotegui, I.  J., Edisawa, M., El-Gamal, Y., Rivas, M. F. … Worm, M. (2020). World Allergy Organization Anaphylaxis Guidance 2020, WAO Journal, 13 (10) 100472,

Coop, C. A., Schapira, R. S., & Freeman, T. M. (2017). Are ACE Inhibitors and Beta-blockers Dangerous in Patients at Risk for Anaphylaxis? J Allergy Clin Immunol Pract. 5(5), 1207-1211.

Du Toit, G., Roberts, G., Sayre, P.H., Bahnson, H.T., Radulovic, S., Santos, A.F., … Lack, G. (2015). LEAP Study Team. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med, 372(9), 803-813.

Duvauchelle, T., Robert, P., Donazzolo, Y., Loyau, S., Orlandini, B., … Schwartz, J-C. (2018). Bioavailability and cardiovasculareffects of adrenaline administered by anapen autoinjector in healthy volunteers. J Allergy Clin Immunol Pract, 6(4),1257-1263.

Frith, K., Smith, J., Joshi, P., Ford, L. S., & Vale, S. (2021). Updated anaphylaxis guidelines: management in infants and children. Aust Prescr, 44, 91-95.

Frith, K., Smith, J., & Katelaris, C. H. (2022). Andrenaline injectors: update on prescribing. Medicine Today, 23(5), 50-57.

Heddle, R. J., Anaphylaxis to stings and bites. (2006). MJA, 185(5), 290., doi: 10.5694/j.1326-5377.2006.tb00564.x 

Hu, W., & Kemp, A., Managing childhood food allergies and anaphylaxis. (2005). Australian Family Physician, 34 (1-2), 1-5.

Jacobsen, K. H., Sambell, R., Devince, A., & Vale, S. (2018). Food Allergy Readiness and Anaphylaxis Management in early childhood education and care in Western Australia. Aust J Early Childhood,

Jarvinen, K. M., Sicherer, S. H., Sampson, H. A., & Nowak-Wegrzyn, A., (2008). Use of multiple doses of epinephrine in food-induced anaphylaxis in children. J Allergy Clin Immunol, 122(1), 131-138.

Hompes, S., Kohli, A., Nemat, K., Scherer, K., Lange, L., Rueff, F., … Worm, M. (2011). Provoking allergens and treatment of anaphylaxis in children and adolescents - data from the anaphylaxis registry of German-speaking countries. Ped Allergy Immunol, 22(6), 568-574.

Kemp, A. S., Action on Anaphylaxis Action Plans (2010), J Paediatr Child Health, 46(10), 554-556.

Lacwik, P., Bialas, A. J., Wielanek, M., Sklodowska, M., Kupczyk, M., Gorski, P., Kuna, P. (2019). Single, short-time exposure to heat in a car during sunny day can decrease epinephrine concentration in autoinjectors: a real-life pilot study. J Allergy Clin Immunol Pract, 7(4), 1362-1364.

Lieberman, P., Nicklas, R. A., Oppenheimer, J., Kemp, S. F., & Land, D. M. (2010). The diagnosis and management of anaphylaxis practice parameter: 2010 update.

Liew, W. K., Williamson, E. W., & Tang, M. L. K. (2008). Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol, 123(2), 434-442.

Loh, R., Mullins, R. J., & Vale, S., (2012). Anaphylaxis. Investigating and managing an allergic emergency. Med Today, 13(9), 16-25.

McCall, S.J., Kurinczuk, J.J. & Knight, M., (2019). Anaphylaxis in Pregnancy in the United States: Risk Factors and Temporal Trends Using National Routinely Collected Data. J Allergy Clin Immunol, 7 (8), 2606-2612.e3.

Mullins, R. J., Anaphylaxis: risk factors for recurrence. (2003). Clin Exp Allergy, 33(8), 1033-1040.

Mullins, R. J., Clark, S., & Camargo, C.A., (2009). Regional variation in epinephrine autoinjector prescriptions in Australia: more evidence for the vitamin D-anaphylaxis hypotheses. Ann Allergy Asthma Immunol, 103(6), 488-495.

Mullins, R. J., Dear, K. B. G., & Tang, M. L. K. (2015). Time trends in Australia hospital anaphylaxis admissions in 1998-1999 to 2011-2012. J Allergy Clin Immunol, 136(2), 367-375.   

Mullins, R. J., Wainstein, B. K., Barnes, E. H., Liew, W. K., & Campbell, D. E. (2016). Increases in anaphylaxis fatalities in Australia from 1997 to 2013. Clin Exp Allergy. 46(8), 1099-1110.

Mullins, R. J., Muraro, A., Worm, A., Alviani, C., Cardona, V., DunnGalvin, A., … Roberts, G. (2022). EAACI guidelines: Anaphylaxis (2021 update). Allergy, 77(2), 357-377.

Mullins, R. J., Dear, K. B. G., and Tang, M. L. K. (2022). Changes in Australian food anaphylaxis admission rates following introduction of updated allergy prevention guidelines. J Allergy Clin Immunol, Food Allergy and Gastrointestinal Disease, 150, (1), 140-145.E1.

Osborne, N. J., Koplin, J. J., Martin, P. E., Gurrin, L. C., Thiele, L., Tang, M. L.K., … Allen, K. J., (2010). The HealthNuts population-based study of paediatric food allergy: validity, safety and acceptability. Clin Exp Allergy, 40(10),1516-1522.

Pharmaceautical Benefits Scheme (PBS) for health professionals. Canberra: Australian Government Department of Health and Ageing.

Poulos, L. M., Waters, A. M., Correll, P.K., Loblay, R. H., & Marks, G. B. (2007). Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol, 120(4), 878-884.

Primeau, M. N., Kagan, R., Joseph, L., Lim, H., Dufresne, C., Duffy, C., … Clarke, A. (2000). The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy, 30(8), 1135-1143.

Pumphrey, R. S. H.  (2003). Fatal posture in anaphylactic shock. J Allergy Clin Immunol, 112 (2), 451-452.

Pumphrey, R. S. H. (2004). Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol, 4(4), 285-290.

Pumphrey, R. S. H., & Gowland, M. H. (2007). Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol, 119(4), 1018-1019.

Pumphrey, R. S. H. & Sturm, G. (2014). Risk factors for fatal anaphylaxis in Moneret-Vautrin, D.A. (ed) Advances in Anaphylaxis Management. Future Medicine, 32-48.

Sampson, H. A., Mendelson, L., & Rosen, J. P. (1992). Fatal and near fatal anaphylactic reactions to food in children and adolescents. N Engl J Med, 327(6), 380-384.

Sampson, H. A., Munoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Bock, S. A., Branum, A., … Decker, W. W. (2006) Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol, 117(2), 391-397.

Savage, J. H., Matsui, E. C., Skripak, J. M., & Wood, R. A. (2007). The natural history of egg allergy, J Allergy Clin Immunol, 120(6), 1413-1417.

Shaker, M. S., Wallace, D. V., Golden, D. B. K., Stukus, D. R., & Wang, J. (2020). Anaphylaxis - a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol, 145(4), 1082-1123.

Sheikh, A., Hippisley-Cox, J., Newton, J., & Fenty, J. (2008). Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med, 101(3), 139-143.

Simons, F. E., Gu, X., & Simona, K. J. (2001). Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol, 108(5) 871-873.

Simons, F. E., Gu, X., & Simona, K. J. (2001). Epinephrine for the out-of-hospital (first-aid) treatment of anaphylaxis in infants: is the ampule/syringe/needle method practical? J Allergy Clin Immunol, 108(6), 1040-1044.

Simons, F. E., First-aid treatment of anaphylaxis to food: focus on epinephrine. (2004). J Allergy Clin Immunol, 113(5), 837-844.

Simons, F. E., & Schatz, M. (2012). Anaphylaxis during pregnancy. J Allergy Clin Immunol, 130(3), 597-606.

Simons, F. E., Ardusso, L. R. F., Dimov, V., Ebisawa, M., El-Gamal, Y. M., Lockey, R. F., & Worm, M. (2013). WAO Anaphylaxis guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol, 162(3), 193-204.

Simons, K. J., & Simons, F. E. R. (2010). Epinephrine and it use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol, 10(4), 354-361.

Skripak, J. M., Matsui, E. C., Mudd, K., & Wood, R. (2007). The natural history of IgE-mediated cow's milk allergy. J Allergy Clin Immunology, 120(5), 1172-1177.

Stafford, A., Patel, N., & Turner, P. J. (2021). Anaphylaxis-moving beyond severity… J Allergy Clin Immunol, 148(1), 83-85.

Stuckey, M., Cobain, T., Sears, M., Cheney, J., & Dawkins, R. L. (1982). Bee venom hypersensitivity in Busselton. Lancet, 3(2), 41.

Summers, C. W., Pumphrey, R. S. H., Woods, C. N., McDowell, G., Pemberton, P. W., & Arkwright, P. D. (2008). Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center. J Allergy Clin Immunol, 121(3), 632-8 e2.

Thomson, H., Seith, R., & Craig, S., (2017). Inaccurate diagnosis of paediatric anaphylaxis in three Australian emergency departments. J Paedriatr Child Health, 52(7), 698-704.

Thong, B., & Tan, T. (2011). Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol, 71(5), 684-700. 

Tole, J. W., & Lieberman, P. (2007). Biphasic anaphylaxis: Review of incidence, clinical predictors and observation recommendations. Immunol Allergy Clin North Am. 27(20), 309-326, viii

Turner, P. J., Jerschow, E., Umasunthar, T., Lin, R., & Campbell, D., (2017). Fatal Anaphylaxis: Mortality Rate and Risk Factors. J Allergy Clin Immunol Prac, 5(5), 1169-1178.

Turner, P. J., Campbell, D. E., Motosue, M. S., & Campbell, R. L. (2020). Global Trends in Anaphylaxis Epidemiology and Clinical Implications. J Allergy Clin Immunol, pii: S2213-2198 (19) 30967-5.

Turner, P., Muraro, A., & Roberts, G., (2021). Pharmacokenetics of adrenaline autoinjectors. Clin Exp Allergy, 52(1), 18-28.

Umasunthar, T., Leonardi-Bee, J., Hodes, M., Turner, P. J. Core, C., Warner, J. O., & Boyle, R. J. (2013). Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis. Clin Exp Allergy, 43(12), 1333-1341.

Vitte, J., & Bongrand, P. (2013). Serum trypase determination in patients with acute allergic reactions. J Allergy and Clinical Immunol, 131(6).

Vale, S., Smith, J., & Loh, R. (2012). Safe use of adrenaline autoinjectors. Australian Prescriber, 35, 56-58.

Vale, S., Smith, J., Said. M., Dunne, G., Mullins, R. J., & Loh, R., (2015). ASCIA guidelines for prevention of anaphylaxis in schools, pre-schools and childcare: 2015 update. J Paed Child Health. 51(10), 949-954.

Yunginger, J. W., Squillace, D. L., Jones, R. T., & Helm Ricki, M., (1989). Fatal anaphylaxis induced by peanuts, Allergy & Asthma Proceedings, 10(4), 249-253.

Content updated August 2022